ArticleThe Journal of organic chemistry2025
Photoactivation of BODIPY Fluorescence with Green Light.
Article in The Journal of organic chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Solvatochromic BODIPYs with Polarity-Independent Absorption for Functional Super-resolution Imaging of Live Cell Membranes.Chemical & biomedical imaging · 2026Article
- Functional super-resolution microscopy of fibers and polymers: convergence of artificial and biological systems at the nanoscale.Nanoscale horizons · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Existing synthetic dyes with photoactivatable fluorescence demand ultraviolet radiation or, at best, violet light for fluorescence photoactivation. Illumination of biological samples within this range of relatively short wavelengths, however, causes significant photodamage. Strategies for the photochemical generation of fluorescent products under irradiation at wavelengths longer than 500 nm with moderate power densities are urgently needed to enable live-cell imaging with negligible phototoxicity. We identified a possible structural design to satisfy these stringent irradiation requirements. Specifically, we demonstrated that illumination of a borondipyrromethene (BODIPY) chromophore in the green region of the visible spectrum cleaves an adjacent oxazine heterocycle to form a fluorescent product with an emission in the red spectral window. We successfully photoactivated this compound with a 561 nm laser and localized single molecules of the fluorescent product with nanometer precision under 581 nm excitation, even in the interior of live cells. Indeed, we reconstructed subdiffraction images of the nanostructured lysosomes of the labeled cells under such unprecedented illumination conditions. Our results clearly indicate that this photochemical strategy for fluorescence photoactivation is a viable one for the realization of very-much needed photoactivatable synthetic dyes for super-resolution imaging with live-cell compatible irradiation requirements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.